Wednesday, February 2, 2022

'Emergency': Pfizer asks FDA to approve COVID shots for children under 5

Pfizer and BioNTech asked the Food and Drug Administration on Tuesday to grant emergency use authorization to administer its COVID-19 vaccine to children younger than 5 years old.

The FDA already has granted emergency use authorization for children between the ages of 5 and 11 despite members of FDA and CDC advisory panels expressing concern that safety data for children regarding Pfizer's COVID vaccine is lacking. And further, children have a nearly 100% survival rate from infection while the current omicron variant generally is producing mild symptoms.

Last week, White House coronavirus adviser Dr. Anthony Fauci said children younger than 4 years old likely will receive three doses of the Pfizer COVID-19 when it’s approved after clinical trials showed two doses were ineffective.